CIK 0000719135 · Non-accelerated filer<br>Smaller reporting company
Apyx Medical Corp
Sign in to watch- Ticker
- APYX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112644611
- Phone
- 7273842323
- Business address
- 5115 ULMERTON ROAD, CLEARWATER, FL, 33760
- Former names
- BOVIE MEDICAL CORP, BOVIE MEDICAL Corp, AN CON GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-26 | Hornsby Todd Executive Vice President | Option exercise 10b5-1 | +15,000 | $1.77 | $27K | 15,000 |
| 2023-06-26 | Hornsby Todd Executive Vice President | Sale 10b5-1 | −15,000 | $7.56 | $113K | 40 |
| 2023-06-26 | Hornsby Todd Executive Vice President | Option exercise · Stock Option (Option to Buy) 10b5-1 | −15,000 | 0 | ||
| 2023-06-06 | Geraghty Michael Director | Option exercise | +10,000 | $2.79 | $28K | 27,500 |
| 2023-06-06 | Geraghty Michael Director | Option exercise · Stock Option (Option to Buy) | −10,000 | 0 | ||
| 2023-01-11 | Hornsby Todd Executive Vice President | Grant or award · Stock Option (Option to Buy) | +100,000 | 100,000 | ||
| 2023-01-11 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Grant or award · Stock Option (Option to Buy) | +72,000 | 72,000 | ||
| 2023-01-11 | Semb Tara Chief Financial Officer | Grant or award · Stock Option (Option to Buy) | +96,000 | 96,000 | ||
| 2023-01-11 | Goodwin Charles D. II Chief Executive Officer | Grant or award · Stock Option (Option to Buy) | +243,000 | 243,000 | ||
| 2022-08-29 | Goodwin Charles D. II Chief Executive Officer | Purchase | +2,000 | $5.93 | $12K | 30,250 |
| 2022-08-29 | Goodwin Charles D. II Chief Executive Officer | Purchase | +9,750 | $5.97 | $58K | 40,000 |
| 2022-08-11 | Waldman Lawrence Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2022-08-11 | MAKRIDES ANDREW Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2022-08-11 | Andres John C. Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2022-08-11 | Levine Wendy Lauren Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2022-08-11 | Baylor-Henry Minnie Director | Grant or award · Stock Option (Option to Buy) | +37,000 | 37,000 | ||
| 2022-08-11 | Swandal Craig A. Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2022-08-11 | Geraghty Michael Director | Grant or award · Stock Option (Option to Buy) | +17,000 | 17,000 | ||
| 2022-07-11 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Option exercise | +30,000 | $2.54 | $76K | 456,504 |
| 2022-07-11 | CITRONOWICZ MOSHE Sr. V.P. of Operations | Option exercise · Stock Option (Option to Buy) | −30,000 | 0 |
Page 4 of 7 · 131 trades